Oct 05, 2022
As per DelveInsight, the Vision Care Market is growing with the development of new products and devices. Eyewear, Intraocular Lenses (IOLS), Contact Lens Solutions driving the market
Read More...
Oct 03, 2022
Presently, the FDA-approved drugs available in the market for CTCL treatment include Istodax, Valchlor, Uvadex, Targretin, and others.
Read More...
Sep 28, 2022
Assistive technologies, such as hearing aids, cochlear implants, and other devices, are playing a key role in Hearing Loss management.
Read More...
Sep 26, 2022
With a strong idiopathic pulmonary fibrosis treatment market presence in place, Boehringer is developing another drug, BI 1015550.
Read More...
Sep 12, 2022
Several severe asthma therapies are currently under investigation by leading pharma goliaths for treating patients with severe asthma.
Read More...
Sep 09, 2022
Pancreatic Cancer treatment outlook is evolving at an immense pace. Globally, several key companies are developing novel therapies
Read More...
Sep 09, 2022
Following the changing alopecia areata treatment scenarios, DelveInsight aims to draw attention to newly approved therapy for alopecia areata.
Read More...
Sep 07, 2022
With the approval from FDA, many Digital Therapeutics products are launched in the market over the years, providing health benefits to patients
Read More...
Sep 05, 2022
To cater to the unmet need in the WHIM syndrome treatment market, leading companies across the globe are working in the therapeutics space
Read More...
Sep 02, 2022
First drug approved in primary sclerosing cholangitis treatment market by companies will have a competitive advantage in therapeutic domain.
Read More...
Understanding Bone Densitometers: Technology, Applications, and Impact on Bone Health
Nov 04, 2025
Wireless Brain Sensors: Revolutionizing Neuroscience and Healthcare
Oct 28, 2025
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
Newsletter/Whitepaper